We continue to take a deep dive into the “Long COVID and Post Acute Sequalae of SARS CoV 2 (PASC): Pathogenesis and Treatment” first-ever international conference on long COVID. Long-COVID research was always going to be a bit messy. Take a look at the...
A distinguished researcher proposes that plasmalogen deficiency plays a key role in ME/CFS and long COVID. While plasmalogen drugs are not available, plasmalogen supplements are. They do tend to be quite expensive, however.
Anticoagulant and anti-platelet therapy reduces symptoms significantly in long COVID. The implications for chronic fatigue syndrome (ME/CFS), fibromyalgia and POTS are discussed.
An innovative gene expression study suggests that an immune cell that's hardly been studied in chronic fatigue syndrome - monocytes - could be the prime driver of the immune problems in the disease.
Please support Health Rising in our Quickie Summer Donation Drive! Our goal is $15,000.Click here for more.
Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News
Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.